150 related articles for article (PubMed ID: 30247545)
21. Phosphorylation of NFATC1 at PIM1 target sites is essential for its ability to promote prostate cancer cell migration and invasion.
Eerola SK; Santio NM; Rinne S; Kouvonen P; Corthals GL; Scaravilli M; Scala G; Serra A; Greco D; Ruusuvuori P; Latonen L; Rainio EM; Visakorpi T; Koskinen PJ
Cell Commun Signal; 2019 Nov; 17(1):148. PubMed ID: 31730483
[TBL] [Abstract][Full Text] [Related]
22. HSPC111 governs breast cancer growth by regulating ribosomal biogenesis.
Zhang C; Yin C; Wang L; Zhang S; Qian Y; Ma J; Zhang Z; Xu Y; Liu S
Mol Cancer Res; 2014 Apr; 12(4):583-94. PubMed ID: 24425784
[TBL] [Abstract][Full Text] [Related]
23. The PIM1 kinase is a critical component of a survival pathway activated by docetaxel and promotes survival of docetaxel-treated prostate cancer cells.
Zemskova M; Sahakian E; Bashkirova S; Lilly M
J Biol Chem; 2008 Jul; 283(30):20635-44. PubMed ID: 18426800
[TBL] [Abstract][Full Text] [Related]
24. The PIM1 kinase promotes prostate cancer cell migration and adhesion via multiple signalling pathways.
Santio NM; Salmela M; Arola H; Eerola SK; Heino J; Rainio EM; Koskinen PJ
Exp Cell Res; 2016 Mar; 342(2):113-24. PubMed ID: 26934497
[TBL] [Abstract][Full Text] [Related]
25. Potential roles for the PIM1 kinase in human cancer - a molecular and therapeutic appraisal.
Shah N; Pang B; Yeoh KG; Thorn S; Chen CS; Lilly MB; Salto-Tellez M
Eur J Cancer; 2008 Oct; 44(15):2144-51. PubMed ID: 18715779
[TBL] [Abstract][Full Text] [Related]
26. PIM1-dependent phosphorylation of histone H3 at serine 10 is required for MYC-dependent transcriptional activation and oncogenic transformation.
Zippo A; De Robertis A; Serafini R; Oliviero S
Nat Cell Biol; 2007 Aug; 9(8):932-44. PubMed ID: 17643117
[TBL] [Abstract][Full Text] [Related]
27. Ribosomal Biogenesis and Translational Flux Inhibition by the Selective Inhibitor of Nuclear Export (SINE) XPO1 Antagonist KPT-185.
Tabe Y; Kojima K; Yamamoto S; Sekihara K; Matsushita H; Davis RE; Wang Z; Ma W; Ishizawa J; Kazuno S; Kauffman M; Shacham S; Fujimura T; Ueno T; Miida T; Andreeff M
PLoS One; 2015; 10(9):e0137210. PubMed ID: 26340096
[TBL] [Abstract][Full Text] [Related]
28. PIM1 kinase inhibitors induce radiosensitization in non-small cell lung cancer cells.
Kim W; Youn H; Kwon T; Kang J; Kim E; Son B; Yang HJ; Jung Y; Youn B
Pharmacol Res; 2013 Apr; 70(1):90-101. PubMed ID: 23352980
[TBL] [Abstract][Full Text] [Related]
29. Pim1 supports human colorectal cancer growth during glucose deprivation by enhancing the Warburg effect.
Zhang M; Liu T; Sun H; Weng W; Zhang Q; Liu C; Han Y; Sheng W
Cancer Sci; 2018 May; 109(5):1468-1479. PubMed ID: 29516572
[TBL] [Abstract][Full Text] [Related]
30. Identification of PIM1 substrates reveals a role for NDRG1 phosphorylation in prostate cancer cellular migration and invasion.
Ledet RJ; Ruff SE; Wang Y; Nayak S; Schneider JA; Ueberheide B; Logan SK; Garabedian MJ
Commun Biol; 2021 Jan; 4(1):36. PubMed ID: 33398037
[TBL] [Abstract][Full Text] [Related]
31. PSCA promotes prostate cancer proliferation and cell-cycle progression by up-regulating c-Myc.
Li E; Liu L; Li F; Luo L; Zhao S; Wang J; Kang R; Luo J; Zhao Z
Prostate; 2017 Dec; 77(16):1563-1572. PubMed ID: 28971496
[TBL] [Abstract][Full Text] [Related]
32. PIM1 accelerates prostate cancer cell motility by phosphorylating actin capping proteins.
Santio NM; Vainio V; Hoikkala T; Mung KL; Lång M; Vahakoski R; Zdrojewska J; Coffey ET; Kremneva E; Rainio EM; Koskinen PJ
Cell Commun Signal; 2020 Aug; 18(1):121. PubMed ID: 32771000
[TBL] [Abstract][Full Text] [Related]
33. Pim1 and Myc reversibly transform murine precursor B lymphocytes but not mature B lymphocytes.
Bouquet C; Melchers F
Eur J Immunol; 2012 Feb; 42(2):522-32. PubMed ID: 22101984
[TBL] [Abstract][Full Text] [Related]
34. Small ribosomal protein subunit S7 suppresses ovarian tumorigenesis through regulation of the PI3K/AKT and MAPK pathways.
Wang Z; Hou J; Lu L; Qi Z; Sun J; Gao W; Meng J; Wang Y; Sun H; Gu H; Xin Y; Guo X; Yang G
PLoS One; 2013; 8(11):e79117. PubMed ID: 24244431
[TBL] [Abstract][Full Text] [Related]
35. Pim family kinases enhance tumor growth of prostate cancer cells.
Chen WW; Chan DC; Donald C; Lilly MB; Kraft AS
Mol Cancer Res; 2005 Aug; 3(8):443-51. PubMed ID: 16123140
[TBL] [Abstract][Full Text] [Related]
36. PIM1: a promising target in patients with triple-negative breast cancer.
Zhao W; Qiu R; Li P; Yang J
Med Oncol; 2017 Aug; 34(8):142. PubMed ID: 28721678
[TBL] [Abstract][Full Text] [Related]
37. NCAPG2 promotes prostate cancer malignancy and stemness via STAT3/c-MYC signaling.
Zhang E; Chen Z; Liu W; Lin L; Wu L; Guan J; Wang J; Kong C; Bi J; Zhang M
J Transl Med; 2024 Jan; 22(1):12. PubMed ID: 38166947
[TBL] [Abstract][Full Text] [Related]
38. Inhibition of PIM1 blocks the autophagic flux to sensitize glioblastoma cells to ABT-737-induced apoptosis.
Remy J; Linder B; Weirauch U; Konovalova J; Marschalek R; Aigner A; Kögel D
Biochim Biophys Acta Mol Cell Res; 2019 Feb; 1866(2):175-189. PubMed ID: 30389373
[TBL] [Abstract][Full Text] [Related]
39. Pim1 kinase is upregulated in glioblastoma multiforme and mediates tumor cell survival.
Herzog S; Fink MA; Weitmann K; Friedel C; Hadlich S; Langner S; Kindermann K; Holm T; Böhm A; Eskilsson E; Miletic H; Hildner M; Fritsch M; Vogelgesang S; Havemann C; Ritter CA; Meyer zu Schwabedissen HE; Rauch B; Hoffmann W; Kroemer HK; Schroeder H; Bien-Möller S
Neuro Oncol; 2015 Feb; 17(2):223-42. PubMed ID: 25155357
[TBL] [Abstract][Full Text] [Related]
40. Antimony enhances c-Myc stability in prostate cancer via activating CtBP2-ROCK1 signaling pathway.
Zhang C; Lu C; Wang Z; Feng G; Du E; Liu Y; Wang L; Qiao B; Xu Y; Zhang Z
Ecotoxicol Environ Saf; 2018 Nov; 164():61-68. PubMed ID: 30098506
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
